# Gen İlaç, 1 Ocak–30 Eylül 2026’da 1,06 milyar TL net kâr elde etti - Bağlantı: https://www.borsatek.com/genil-2026-9-ay-finansal-sonuclar/ - Yayımlanma: 2026-10-26T19:18:05+03:00 - Yazar: Haber Merkezi GEN İlaç (GENIL), 1 Ocak–30 Eylül 2026 döneminde ana ortaklık paylarına düşen 1.062.163.587 TL net kâr elde etti. Şirketten KAP’a gönderilen bildirime göre, dönem kârı 1.058.815.757 TL oldu; hasılat 20.542.939.732 TL olarak gerçekleşti. Toplam varlıklar 27.607.811.680 TL’ye, toplam yükümlülükler 13.813.106.260 TL’ye, toplam özkaynaklar 13.794.705.420 TL’ye ulaştı. Ana ortaklığa ait özkaynaklar 13.806.565.105 TL seviyesinde kaydedildi; ödenmiş sermaye 4.500.000.000 TL, geri alınmış paylar -147.425.891 TL ve geçmiş yıllar kârları 4.186.443.527 TL oldu. Finansal Tablolar ![Finansal Durum Tablosu (Bilanço)](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-fin-1687639-t01.png) ![Kar veya Zarar Tablosu](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/ kap-fin-1687639-t02.png) ![Kar veya Zarar Tablosu](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/ kap-fin-1687639-t03.png) ![Nakit Akış Tablosu](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/kap- fin-1687639-t04.png) ![Kar veya Zarar Tablosu](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/ kap-fin-1687639-t05.png) 📎 Bildirim Ekleri [📄GENIL.pdfPDF](https://www.borsatek.com/kap-git/?u=aHR0cHM6Ly93d3cua2FwLm9yZy50ci90ci9hcGkvZmlsZS9kb3dubG9hZC80MDI4MzI4Y2ExNmM3ZGU1MDFhMTc4NDlhODJmMzQ1OQ) Bildirim Eki Sayfaları ![GENIL.pdf — sayfa 1](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p01.webp) ![GENIL.pdf — sayfa 2](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p02.webp) ![GENIL.pdf — sayfa 3](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p03.webp) ![GENIL.pdf — sayfa 4](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p04.webp) ![GENIL.pdf — sayfa 5](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p05.webp) ![GENIL.pdf — sayfa 6](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p06.webp) ![GENIL.pdf — sayfa 7](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p07.webp) ![GENIL.pdf — sayfa 8](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p08.webp) ![GENIL.pdf — sayfa 9](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p09.webp) ![GENIL.pdf — sayfa 10](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p10.webp) ![GENIL.pdf — sayfa 11](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p11.webp) ![GENIL.pdf — sayfa 12](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p12.webp) ![GENIL.pdf — sayfa 13](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p13.webp) ![GENIL.pdf — sayfa 14](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p14.webp) ![GENIL.pdf — sayfa 15](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p15.webp) ![GENIL.pdf — sayfa 16](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p16.webp) ![GENIL.pdf — sayfa 17](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p17.webp) ![GENIL.pdf — sayfa 18](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p18.webp) ![GENIL.pdf — sayfa 19](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p19.webp) ![GENIL.pdf — sayfa 20](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p20.webp) ![GENIL.pdf — sayfa 21](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p21.webp) ![GENIL.pdf — sayfa 22](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p22.webp) ![GENIL.pdf — sayfa 23](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p23.webp) ![GENIL.pdf — sayfa 24](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p24.webp) ![GENIL.pdf — sayfa 25](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p25.webp) ![GENIL.pdf — sayfa 26](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p26.webp) ![GENIL.pdf — sayfa 27](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p27.webp) ![GENIL.pdf — sayfa 28](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p28.webp) ![GENIL.pdf — sayfa 29](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p29.webp) ![GENIL.pdf — sayfa 30](https://i3.wp.com/www.borsatek.com/app/uploads/2026/10/kap- 4028328ca16c7de501a17849a82f3459-p30.webp)